Professional Documents
Culture Documents
ESOPHAGUS
Atresia, Fistula (tracheo-esophageal)
Diverticula
Stenosis
Hiatal hernia
Esophageal webs & Rings
Achalasia cardia
Lacerations (Mallory- Weiss syndrome)
Esophageal diverticulum
ESOPHAGEAL WEB
Location
Imaging Findings
ESOPHAGEAL WEB
REFLUX ESOPHAGITIS:
Reflux of gastric contents into lower
esophagus
CAUSES
Clinical features
* Dysphagia,
* Heartburn,
Complications:
* Bleeding,
* Stricture,
* Barrett esophagus formation
* Dental erosion
BARRETTS ESOPHAGUS
Distal squamous epithelium of the
esophagus is replaced by metaplastic
columnar epithelium
Recurrent exposure of acid rich contents
on the lower end (following GERD)
Greater risk for Ca esophagus
Adenocarcinoma
Barrett esophagus
ACHALASIA CARDIA
Absence of Myentric plexus of Auerbach
within the submucosa of lower end of
esophagus
Progressive dilatation of proximal part of
normal esophagus segment
Diagnosis is by Barium swallow & (Barium
meal)
M : F = 20 : 1,
Incidence - Variable
Lifestyle:
Alcohol consumption
Tobacco use
Preexistent Esophageal disorders
Longstanding Esophagitis
Achalasia
Plummer-Vinson syndrome
Morphology:
GROSS:
* Polypoid - 60%,
* Flat - - - - - 15%,
* Excavating - 25%
20%
50%
30%
STARTS AS
IN-SITU-CARCINOMA
Sepsis,
Tracheo-esophasgeal Fistula
PROGNOSIS:
ADVANCED - 25%
[Local & distant spread common ]
ADENOCARCINOMA of
Esophagus
Most common tumor in the distal end of
Esophagus
Secondary to long standing Barretts
Esophagus
Genetic predisposition: Point mutation in
p53 gene
Other risk factors like alcohol, Smoking
associated
Esophagus - Adenocarcinoma
NORMAL STOMACH
Stomach::
Cardia
Fundus
Body
Antrum
Pylorus
Cells:: Mucous secreting cells
Parietal cells or Oxyntic cells (HCL, IF)
Chief cells or Peptic cells (Pepsinogen)
Endocrine cells-G cells
ACUTE GASTRITIS
An important cause of GI bleeding
An acute mucosal inflammatory process
In severe cases bleeding & erosions
PATHOGENESIS
An imbalance between
aggressive factors ( acid & pepsin )
and
those that defend the
mucosa
Mucosal defence
Normal
Duodenal
ulcer
Gastric
ulcer
ETIOLOGY
CHRONIC GASTRITIS
Presence of chronic inflammatory
changes
Mucosal atrophy & epithelial Metaplasia
Dysplasia
CARCINOMA
PATHOGENESIS
Helicobacter pylori infection
Autoimmune
H . pylori INFECTION
Chronic gastritis
Peptic ulcer disease
Gastric Carcinoma
Gastric Lymphoma
H . pylori
Gram - ve curved bacillus well adapted to
gastric environment.
Motility
Urease
Binding to gastric epithelial cells via
bacterial adhesin
Helicobacter Pylori
Silver stain
Giemsa stain
Group - O
HLA - B5
Monozygotic twins
Genetically Determined Syndromes
ZE Syndrome
Systemic Mastocytosis
Gastric Ulcer
Complications
of gastric
ulcers (either
benign or
malignant)
include pain,
bleeding,
perforation,
and
obstruction.
GASTRIC ULCER
Duodenal Ulcer
Perforation:
Epidemiology of Gastric
Carcinoma
Higher in Japan, China compared to US,
UK
More common in lower socio-economic
groups
Male to Female ratio is 2: 1
Steady decline in incidence & mortality for
the past 6 decades
Risk factors:
25% Cardia
Morphology:
40% Lesser curvature
12%
50 - 60%
Greater curvature
INCIDENCE OF GASTRIC
CARCINOMA AT DIFFERENT
SITES
CLASSIFICATION
Gastric carcinoma classification is based on
- Depth of Invasion (Early & Advanced)
- Morphologic type (Exophytic, Flat,
excavated, Linitis plastica)
- Histologic type (Intestinal type, Diffuse
type)
Depth of invasion
Early gastric carcinoma - lesion
confined to mucosa & submucosa
regardless of presence / absence of LN
Advanced gastric carcinoma - lesion
has extended below submucosa into
muscular wall
Morphologic types of
Carcinoma Stomach
Fungating
Ulcerating
Diffuse
Clinical features
Insidious , asymptomatic until late in
course
Weight loss , abdominal pain .
Spread
Penetrate wall & spread to regional &
distant LN
Virchow node
Local invasion into duodenum , pancreas
retroperitoneum
Metastasis to liver , lung , peritoneal
seedlings
Krukenberg tumor
Spread of Gastric Ca
Disorders of Intestine
Intestinal Obstruction:
Paralytic ileus
Tumors
Volvulus
Intussusception
Hernia
Diverticular Disease
Outpouchings of colon, particularly in
rectosigmoid colon
Disease of Western civilization and has
risen since 1900
Most affected individuals asymptomatic
Only 20% of cases have clinical
manifestations
Incidence of Diverticulosis
Uncommon before age 40
Post-mortem reports suggest up to 50% of
over 60 years
Left-sided in industrialized countries
Right-sided in Japan
Due to low fiber diet resulting in
intraluminal hypertension
Diverticula
Diverticula
Chronic inflammation
Crypt distortion/atrophy
Surface villiform change
Basal plasmacytosis
Diagnosis of IBD
Clinical history
Physical exam
Endoscopic exam
Radiographic exam
Histologic exam
Serologies
Crohns Disease
Intermittent diarrhea, pain, fever
Epidemiological peaks in 20-30s, another
in 60-70s
Stress associated with flare-ups
Extraintestinal manifestations
Arthritis/joint pain
Erythema nodosum
Skip lesions
Crohns disease
Stricture
Crohns disease
Cobblestoned mucosa
Ulcerative Colitis
Epidemiological peak in 20-30s
Recurring attacks of bloody mucoid
diarrhea lasting several days
Lower abdominal pain relived by
defecation
Ulcerative Colitis
Extraintestinal manifestations
Arthritis/joint pain
hepatic involvement (Primary Sclerosing
Cholangitis)
Oral Aphthous ulcers
Ulcerative Colitis
Proximal
Distal
Colorectal adenocarcinoma
Older patients (>60)
Geographic differences (US highest) dietary and lifestyle
NSAIDS protective
Colorectal adenocarcinoma
Polypoid and exophytic (right-sided)
Present with anemia
Circumferential (left-sided)
Colorectal adenocarcinoma
Anal canal
Adenocarcinoma (usually extension of
rectal)
Squamous cell carcinoma
HPV infection
Immunosuppressed (AIDS)
Appendix
No known function
Rich in lymphoid tissue
Atrophies during life
Acute Appendicitis
Any age group, but especially in children
False positive diagnosis (surgery when not
needed) in 20-25%
Outweighed by morbidity and mortality of
perforation
Acute Appendicitis
Classic presentation
Acute Appendicitis
LICHEN PLANUS
Liver Functions:
Metabolism Carbohydrate, Fat &
Protein
Secretory bile, Bile acids, salts &
pigments
Excretory Bilirubin, drugs, toxins
Synthesis Albumin, coagulation factors
Storage Vitamins, carbohydrates etc.
Detoxification toxins, ammonia, etc.
Disorders of Liver:
Acute Liver Disorder:
Congenital Disorders:
Tumors:
Dark urine
Pale stools
Biliary obstruction
Oedema
Steatorrhoea
Bile obstruction.
Pruritis
Ascitis
Bleeding
Hematemesis
Encephalopathy
Jaundice
Yellow discoloration of skin & sclera due to
excess serum bilirubin. >40umol/l,
(3mg/dl)
Conjugated & Unconjugated types
Obstructive & Non Obstructive (clinical)
Pre-Hepatic, Hepatic & Post Hepatic
types
Jaundice - Not necessarily liver disease *
Jaundice
Jaundice
Cirrhosis:
End stage complication of liver disease
Diffuse disorder of liver characterised by;
Complete loss of architecture, Replaced by
extensive fibrosis with, Regenerating
parenchymal nodules.
Etiology of Cirrhosis
60-70%
10%
5-10%
5%
10-15%
rare
Cirrhosis
Clinical
Features
Ascitis in Cirrhosis
Gynaecomastia in cirrhosis
Complications:
Congestive splenomegaly.
Bleeding varices.
Hepatocellular failure.
Hepatic encephalitis / hepatic coma.
Hepatocellular carcinoma.
Pathogenesis of Hepatic
Encephalopathy
BRAIN
Porta systemic
shunts
LIVER
Toxic N2 metabolites
From Intestines
HEPATITIS VIRUSES:
Hepatitis
Hepatitis
Hepatitis
Hepatitis
Hepatitis
Hepatitis
A
B
C
D
E
G
virus,
virus,
virus,
virus,
virus,
virus;
Hepatitis A
Hepatitis A
Spread: fecal-oral route,
Shed in stool 2 to 3 wks. Before to 1 wk. After
jaundice
Endemic:
* Affects commonly children,
* Substandard hygiene and sanitation,
* Waterborne,
25% of evident acute hepatitis,
Fatality rate: 0.1% ( Fulminant hepatitis);
HEPATITIS B
Can cause:
1.
2.
3.
4.
5.
6.
7.
Acute hepatitis,
Nonprogressive chronic hepatitis,
Progressive chronic hepatitis,
Fulminant hepatitis,
Asymptomatic carrier state,
Backdrop for hepatitis D virus,
Hepatocellular carcinoma;
Hepatitis B
TRANSMISSION:
Hepatitis B
Acute H epatitis B Virus Infection w ith Recovery
Typical Serologic Course
S ym ptom s
HB eAg
anti-HB e
Titer
Total anti-HBc
IgM anti-HBc
anti-HBs
HBsAg
12
16
20
24
28
32
36
52
100
Chronic
(6 months)
(Years)
HBeAg
anti-HBe
HBsAg
Titer
Total anti-HBc
IgM anti-HBc
12 16 20 24 28 32 36
52
HBsAg
HBeAg
HBV DNA
IgM HBc
IgG HBc
IgG HBsAg
Anti HBs
Window
Period
Acute
Hepatitis
Chronic
Hepatitis
Prior
Infection
Immunization
Subclinical
disease
60 - 65%
Acute
infection
4%
Acute
20-25% Hepatitis
Healthy
Carrier
5 - 10%
Persistent
Infection
10-33%
100%
RECOVERY
99%
FULMINANT
< 1% HEPATITIS
DEATH
RECOVERY
67 - 90%
CIRRHOSIS
10%
DEATH
Hepatitis C virus:
Distribution -- Worldwide,
Transmission:
* Blood transfusions ( 90 = 95%)
* Inoculations,
* Sexual both hetero and homo,
* Vertical transmission,
RESOLUTION
15%
A
C
U
T
E
STABLE
DISEASE
STABLE
CIRRHOSIS
I
80%
N
CHRONIC
50%
F
HEPATITIS
E 85%
20%
CIRRHOSIS
C
T
50% DEATH
I Rare
O
FULMINANT
HEPATOCELLULAR
N
HEPATITIS
CARCINOMA
House contacts,
Homosexuals,
Hemodialysis patients,
Hemophiliacs,
I V drug abusers ( 50 to 90% )
Patients with unexplained cirrhosis >
> 50 % HCV Infection
High rate of progression to cirrhosis,
-- > 50%
Hepatitis C
Anti-HCV
Symptoms +/-
Titer
HCV RNA
ALT
Normal
0
Months
Years